LexaGene is developing on-site, automated and sensitive instrumentation for rapid pathogen detection for veterinary diagnostics, food safety, and other markets.
Our breakthrough technology will transform how pathogens are detected and deliver results in about an hour.
22 October 2018 – LexaGene successfully unveils LX2™ beta prototype design to veterinary professionals at the AAVLD conference.
Innovation in the Making
Imagine a new way of testing on site for multiple pathogens that uses customized genetic screening, doesn’t require a skilled technician,
and returns results in just one hour. See what’s new with LexaGene and how we are changing the future of pathogen detection.
LexaGene featured on Fox Biz TV
LexaGene was featured on an episode of Innovations with Ed Begley Jr. which aired on Fox Business Network in fall 2017. Learn more about LexaGene by watching the segment.
LexaGene Company Presentation
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest and return results in about an hour.
LX2 Unveiling at AAVLD on Oct. 20, 2018
LexaGene unveiled LX2 prototype design to veterinary diagnostics audience on October 20th, 2018 at the AAVLD Annual Meeting in Kansas City.